OrthoPediatrics Corp
Price
FilingsNewest: 10-Q, Quarterly reportAug 5 →InsidersNo open-market buys. 9 insiders sold $47.8M, 0 of 26 sales on a 10b5-1 plan.→HoldersBrown Advisory 6.4%BlackRock 4.9%Braidwell 4.2%→Financing →PeersClosest companies: TMCI, SIBN, GMED→
From the filings
Figures
- Revenue
- $252.7Mlast 12 months
- Net income
- −$39.7Mlast 12 months
- Operating cash flow
- −$4.0Mlast 12 months
- Cash and equivalents
- $17.0Mat the last balance sheet
- Total debt
- $102.0Mat the last balance sheet
- Shares outstanding
- 26.1M shareson issue